Some strains of this opportunistic pathogen are also increasingly becoming resistant to the drugs designed to treat them.
Disiplin ilmiah, gaya jurnalistik
Artikel-artikel mengenai Pneumonia
Menampilkan 1 - 20 dari 41 artikel
Hybrid viruses can emerge from co-infections. And we don’t know their effects.
There are a number of pathogens which are reported to be causing the outbreak of respiratory illness in China.
The impact of housing quality extends beyond health to education and subsequent economic outcomes, particularly for children.
Even otherwise healthy children can end up in hospital with this winter respiratory virus.
Infections caused by this bacterium are most common in school-aged children – and can lead to pneumonia.
Africa is suffering from a silent, but costly, epidemic of fungal infections.
Drug-resistant microbes are a serious threat for future pandemics, but the new draft of the WHO’s international pandemic agreement may not include provisions for antimicrobial resistance.
Similar to the patterns seen with COVID-19, flu and RSV, HMPV is making a comeback after years of being repressed by people wearing masks and social distancing.
COVID-19 causes lung injury and lowers oxygen levels in patients because the SARS-CoV-2 virus attacks cells’ mitochondria. This attack is a throwback to a primitive war between viruses and bacteria.
Problems arise when there are too many unwarranted visits to GPs for cold symptoms. Occasionally, though, a cold might turn into something that needs specific diagnosis and treatment.
Of the 20 million people living with sickle cell disease globally, more than 66% are in sub-Saharan Africa.
Sepsis onset can be difficult to recognize, in part because its symptoms can mimic those of many other conditions. A treatment delay of even a few hours can make the difference between life and death.
A lot has changed in COVID treatment since the pandemic began. Here are the treatments you can expect — from being diagnosed, to going to hospital, and for those who need to be cared for in ICU.
As many teens and adults in the US restart their social lives, parents of children under the age of 12 wonder when their kids will also be able to experience the freedom that comes with vaccination.
The risk of coronaviruses jumping species is low, but if you look for it, you will find it.
An effective oxygen system requires prompt recognition of who needs oxygen, a reliable oxygen supply and safe delivery to those who need it.
Public health measures have helped control COVID-19 in Australia. But they’ve affected other winter viruses, too.
Digital participatory surveillance allows the community to share in the responsibility of disease surveillance and contribute to the control and prevention of respiratory disease outbreaks.
It takes around 61 hours to identify the pathogen causing a patient’s pneumonia. A new test reduces that to four hours.
Kontributor teratas
-
Associate Professor, University of Melbourne, Murdoch Children's Research Institute
-
Clinical head, General Intensive Care Unit, Royal Children's Hospital, The University of Melbourne
-
Professor of Veterinary Infectious Diseases, University of Liverpool and International Livestock Research Institute, Kenya, University of Liverpool
-
Lecturer in Virology, Queen's University Belfast
-
Associate Professor of Medicine, Infectious Diseases Physician, Australian National University
-
Senior Lecturer in General Practice, The University of Queensland
-
Professor of Medicine, Pharmacology and Biomedical Engineering, University of Illinois Chicago
-
Assistant Professor of Internal Medicine, Intensivist, University of Michigan
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Associate Professor of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan
-
Executive Director, National COVID-19 Clinical Evidence Taskforce, and Professor, School of Public Health and Preventive Medicine, Monash University
-
Dean of the Faculty of Medicine and Health Sciences, University of Nottingham
-
Director, Evidence and Methods, National COVID-19 Clinical Evidence Taskforce; Associate Professor (Research), Cochrane Australia, School of Population Health and Preventive Medicine, Monash University, Monash University
-
Medical Epidemiologist at the National Institute of Communicable Diseases and Lecturer at the School of Public Health, University of the Witwatersrand
-
Professor of Infectious Diseases and Microbiology, Australian National University
